Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERRARI study of rapid subcutaneous fentanyl titration for cancer pain
NL-OMON60088Phase 4Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of fentanyl in cancer pain, sponsored by Erasmus MC. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on NL-OMON60088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60088.